Literature DB >> 10828992

Investigation of the DsbA mechanism through the synthesis and analysis of an irreversible enzyme-ligand complex.

J Couprie1, F Vinci, C Dugave, E Quéméneur, M Moutiez.   

Abstract

Approaching the molecular mechanism of some enzymes is hindered by the difficulty of obtaining suitable protein-ligand complexes for structural characterization. DsbA, the major disulfide oxidase in the bacterial periplasm, is such an enzyme. Its structure has been well characterized in both its oxidized and its reduced states, but structural data about DsbA-peptide complexes are still missing. We report herein an original, straightforward, and versatile strategy for making a stable covalent complex with a cysteine-homoalanine thioether bond instead of the labile cystine disulfide bond which normally forms between the enzyme and polypeptides during the catalytic cycle of DsbA. We substituted a bromohomoalanine for the cysteine in a model 14-mer peptide derived from DsbB (PID-Br), the membrane partner of DsbA. When incubated in the presence of the enzyme, a selective nucleophilic substitution of the bromine by the thiolate of the DsbA Cys(30) occurred. The major advantage of this strategy is that it enables the direct use of the wild-type form of the enzyme, which is the most relevant to obtain unbiased information on the enzymatic mechanism. Numerous intermolecular NOEs between DsbA and PID could be observed by NMR, indicating the presence of preferential noncovalent interactions between the two partners. The thermodynamic properties of the DsbA-PID complex were measured by differential scanning calorimetry. In the complex, the values for both denaturation temperature and variation in enthalpy associated with thermal unfolding were between those of oxidized and reduced forms of DsbA. This progressive increase in stability along the DsbA catalytic pathway strongly supports the model of a thermodynamically driven mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828992     DOI: 10.1021/bi992873f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Description of the topographical changes associated to the different stages of the DsbA catalytic cycle.

Authors:  Floriana Vinci; Joël Couprie; Piero Pucci; Eric Quéméneur; Mireille Moutiez
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

2.  Cloning of Soluble Human Stem Cell Factor in pET-26b(+) Vector.

Authors:  Salman Asghari; Mahmoud Shekari Khaniani; Masood Darabi; Sima Mansoori Derakhshan
Journal:  Adv Pharm Bull       Date:  2013-12-23

3.  Co-expression of Dsb proteins enables soluble expression of a single-chain variable fragment (scFv) against human type 1 insulin-like growth factor receptor (IGF-1R) in E. coli.

Authors:  Xue-Wen Sun; Xiao-Hua Wang; Yan-Bing Yao
Journal:  World J Microbiol Biotechnol       Date:  2014-09-26       Impact factor: 3.312

4.  The structure of the bacterial oxidoreductase enzyme DsbA in complex with a peptide reveals a basis for substrate specificity in the catalytic cycle of DsbA enzymes.

Authors:  Jason J Paxman; Natalie A Borg; James Horne; Philip E Thompson; Yanni Chin; Pooja Sharma; Jamie S Simpson; Jerome Wielens; Susannah Piek; Charlene M Kahler; Harry Sakellaris; Mary Pearce; Stephen P Bottomley; Jamie Rossjohn; Martin J Scanlon
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

Review 5.  Strategies to optimize protein expression in E. coli.

Authors:  Dana M Francis; Rebecca Page
Journal:  Curr Protoc Protein Sci       Date:  2010-08

6.  Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2009-05-14       Impact factor: 5.328

Review 7.  Structural bioinformatic analysis of DsbA proteins and their pathogenicity associated substrates.

Authors:  Carlos Santos-Martin; Geqing Wang; Pramod Subedi; Lilian Hor; Makrina Totsika; Jason John Paxman; Begoña Heras
Journal:  Comput Struct Biotechnol J       Date:  2021-08-14       Impact factor: 7.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.